Clinical Trial Update: Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant [Phase 3]

View source ↗

Summary

Phase 3 trial updating chlorhexidine gluconate cleansing for preventing central line-associated bloodstream infections and MDR organism acquisition in young can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infection
• Benign Neoplasm
• Childhood Acute Lymphoblastic Leukemia
• Childhood Acute Myeloid Leukemia
• Malignant Neoplasm
• Methicillin-resistant Staphylococcus Aureus Infection
• Myeloid Neoplasm

Snippet

Sponsor: Children's Oncology Group | Conditions: Bacterial Infection, Benign Neoplasm | Phase 3 | Status: COMPLETED | Results posted: 2020-04-08